Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Inventory (2016 - 2025)

Conmed (CNMD) has disclosed Inventory for 16 consecutive years, with $355.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Inventory rose 2.55% year-over-year to $355.5 million, compared with a TTM value of $355.5 million through Dec 2025, up 2.55%, and an annual FY2025 reading of $355.5 million, up 2.55% over the prior year.
  • Inventory was $355.5 million for Q4 2025 at Conmed, down from $364.4 million in the prior quarter.
  • Across five years, Inventory topped out at $364.4 million in Q3 2025 and bottomed at $205.8 million in Q1 2021.
  • Average Inventory over 5 years is $306.8 million, with a median of $324.1 million recorded in 2023.
  • The sharpest move saw Inventory skyrocketed 43.46% in 2022, then decreased 4.21% in 2023.
  • Year by year, Inventory stood at $231.6 million in 2021, then soared by 43.46% to $332.3 million in 2022, then fell by 4.21% to $318.3 million in 2023, then increased by 8.92% to $346.7 million in 2024, then increased by 2.55% to $355.5 million in 2025.
  • Business Quant data shows Inventory for CNMD at $355.5 million in Q4 2025, $364.4 million in Q3 2025, and $362.3 million in Q2 2025.